RSV Vaccination
RSV (Respiratory Syncytial Virus) is a common respiratory virus that typically causes mild, cold-like symptoms in most people. However, it can lead to severe respiratory illness, particularly in vulnerable populations.
Our private pharmacy offers a convenient and reliable RSV vaccination service to help protect individuals, particularly those at higher risk, from severe RSV infections.
Book an RSV Vaccination
RSV vaccination is suitable for people who are 60 and over, and for pregnant women to provide passive protection against RSV in infants from birth through to 6 months of age.
We offer personalised advice to determine eligibility and ensure you receive the right vaccine for your needs. Book your appointment today and safeguard your health against RSV this season.
Appointment fee £75
Single dose £215
To book this service, please click the button below and choose a date and time that suits you.
Book Online
Safe, private clinic
Our beautiful award-winning clinic is in the centre of Winchester and we look forward to welcoming you. Keeping you and others safe is our priority and so if you are unwell, please let us know in advance and we will make appropriate arrangements.
Trained clinicians
Your appointment will be with a highly trained clinician in one of our private consultation rooms at our clinic in Winchester. We will advise you to ensure that you only receive treatment that is appropriate so you are protected and safe.
Private Pharmacy
We operate within a registered private pharmacy which means that we can discuss and provide any required treatments, tests or referrals as appropriate. You can also be assured that we work within a strict governance framework.
About this appointment
During your appointment our trained clinician will discuss health history, travel plans and any factors which may affect the use of a vaccine. This will ensure that any vaccine provided is appropriate and safe.
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
About RSV
RSV is a common cause of respiratory tract infections. It usually causes a mild self-limiting respiratory infection in adults and children, but it can be severe in infants and older adults who are at increased risk of acute lower respiratory tract infection, including bronchiolitis in infants.
RSV bronchiolitis in the pre-immunisation era was an important cause of emergency department attendances and amongst the leading causes of infant hospital admissions, with an average annual admission rate of 35.1 per 1000 infant under one year old.
In the UK prior to the introduction of universal RSV immunisation, the virus was estimated to cause annually around 33,500 hospitalisations in children under 5 years and 20 to 30 child deaths. Most RSV admissions happen to full-term children without underlying risk factors. Birth months August to November are a risk factor for admission; these infants are younger, with correspondingly smaller airways, during peak RSV seasonal activity and have less well-developed immune systems than older infants.
Prematurity is similarly an important risk factor for admission in infancy.
RSV is now recognised to have a significant burden in immunocompromised and elderly adults. It may manifest as exacerbations of underlying chronic obstructive pulmonary disease or cardiovascular disease. In immunocompromised patients, RSV can cause severe infections with mortality rates as high as 80%. Immunosenescence of T-cell responses may be a factor in vulnerability to severe RSV infection in older adults.
Our service provides access to the latest approved RSV vaccines, administered by qualified professionals in a safe and welcoming environment.
We offer personalised advice to determine eligibility and ensure you receive the right vaccine for your needs.
Book your appointment today and safeguard your health against RSV this season.
About the RSV Vaccine
At REMEDI HEALTH, we offer a recombinant RSV vaccine. It is bivalent, containing recombinant RSV prefusion F protein (pre-F) antigens developed from each of subtypes A and B.
The vaccine is licensed for prevention of RSV respiratory infections in individuals from 60 years of age and to protect infants from RSV through vaccination of pregnant women. The maternal indication is licensed to be given between 28 and 36 weeks gestation
The full duration of protection offer by the RSV vaccine in older adults is unknown but is at least two years. There are no current data to support revaccination of older adults after a first dose.
Currently all adults turning 75 years old should be offered by hte NHS a single dose of the RSV vaccine and all adults aged 75-79 years old as a catch-up programme to ensure protection ahead of and during any subsequent RSV season.
However many other individuals who are not eligible on the NHS would benefit from an RSV vaccine and can book in for a private vaccination.
Can we help you?
Our team are standing by to help you with any questions or queries that you may have. We can advise you on the best test, product or service for your requirements.
